United States Veterinary Oncology Diagnostics Market to Grow with a CAGR of 8.48% through 2030
Growing adoption
of advanced diagnostic tools and rising prevalence of cancer in companion
animals are encouraging early detection and treatment, is expected to drive the
United States Veterinary Oncology Diagnostics Market growth in the forecast
period, 2026-2030
According to
TechSci Research report, “United States Veterinary Oncology Diagnostics
Market – By Region, Competition, Forecast & Opportunities, 2030F”,
the United States Veterinary Oncology Diagnostics Market was valued at USD 985.24 Million in
2024 and is expected to reach USD 1607.87 Million by 2030 with a CAGR of 8.48%. The United States Veterinary
Oncology Diagnostics Market is expanding rapidly due to advancements in
technology and growing interest in pet health. Pet owners are increasingly
aware of the risks associated with untreated cancers and are seeking early detection
solutions to ensure their pets receive timely care. This awareness, coupled
with a rising pet population and improved access to veterinary care, has
increased the demand for innovative oncology diagnostics. The adoption of
cutting-edge tools such as genetic testing, molecular imaging, and liquid
biopsy has improved diagnostic accuracy and enabled personalized treatment
approaches. These advancements allow for better identification of various
cancer types in animals, from soft tissue tumors to more complex conditions,
thus fueling market growth.
A
significant trend in the market is the shift toward non-invasive diagnostic
methods. Pet owners and veterinary professionals are moving away from
traditional, invasive biopsy techniques in favor of less invasive alternatives
such as blood tests and imaging technologies. These non-invasive methods reduce
stress on pets and lead to quicker diagnosis and treatment. Another notable
trend is the rise in collaborative care, where veterinary oncologists, general
practitioners, and pet owners work together to formulate comprehensive
treatment plans. Such collaborative approaches improve patient outcomes,
creating greater demand for oncology diagnostics and treatment services.
There
are several growth opportunities in the United States Veterinary Oncology
Diagnostics Market, particularly in enhancing accessibility and affordability.
Expanding pet insurance coverage to include more comprehensive oncology care
would help reduce financial barriers and allow more pet owners to access
advanced diagnostic and treatment services. The development of cost-effective
diagnostic tools, such as affordable genetic tests and point-of-care devices,
also presents a significant opportunity to make cancer diagnostics more
accessible. Furthermore, increasing partnerships between veterinary clinics and
diagnostic laboratories can improve service availability in underserved areas,
ensuring that more pets can benefit from early cancer detection. As the market
continues to grow, these opportunities can drive innovation and ensure better
outcomes for both pets and their owners.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "United States Veterinary Oncology Diagnostics Market”
The United
States Veterinary Oncology Diagnostics Market is segmented into animal type, test
type, cancer type, end user, regional distribution, and company.
Based on the Cancer
Type, Skin Cancers emerged as the fastest growing segment in the United States Veterinary
Oncology Diagnostics Market during the forecast period. This is due to the
increasing incidence of skin tumors in companion animals, particularly dogs and
cats. The rise in skin cancer cases can be attributed to several factors,
including greater exposure to environmental factors like UV radiation, which
can lead to the development of tumors such as mast cell tumors, melanomas, and
squamous cell carcinomas. As more pet owners become aware of the potential
risks and signs of skin cancer, the demand for diagnostic testing has surged,
fueling market growth. Veterinary practices are increasingly adopting advanced
diagnostic tools, such as molecular diagnostics, histopathology, and imaging
technologies, to accurately diagnose skin cancers at an early stage. Early detection
is crucial for effective treatment and improving the prognosis of affected
pets, driving the need for more specialized oncology diagnostics in the market.
Based
on the Region, West emerged as the fastest growing region in the United
States Veterinary Oncology Diagnostics Market during the forecast period. This is due to a combination of
factors. The region is home to some of the country's leading veterinary
hospitals and specialty oncology centers, offering advanced diagnostic and
treatment options for pets. California, in particular, is known for its high
concentration of pet owners who are increasingly proactive about their pets'
health, including cancer prevention and early detection. The West also benefits
from a robust healthcare infrastructure, which includes access to cutting-edge
diagnostic technologies, such as molecular diagnostics, advanced imaging, and
biomarker testing, facilitating early and accurate detection of cancer in animals.
Additionally, veterinary professionals in the region are often at the forefront
of adopting new technologies and treatment modalities, further driving market
growth.
Major
companies operating in United States Veterinary Oncology Diagnostics Market
are:
- Zoetis
Inc.
- Neogen
Corporation
- Antech
Diagnostics, Inc.
- IDEXX
Laboratories, Inc.
- Embark
Veterinary, Inc.
- Boehringer
Ingelheim Animal Health USA Inc.
- Arizona
Veterinary Oncology
- Varian
Medical Systems, Inc.
- Merck
& Co., Inc.
- Oncotect,
Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The United States Veterinary Oncology
Diagnostics Market is expanding due to the increasing investments in veterinary
cancer research and the development of innovative diagnostic technologies.
Research organizations and veterinary clinics are focusing on creating more
efficient and affordable diagnostic tests for cancer in pets, thus increasing
the accessibility of advanced diagnostic options for pet owners. Collaboration
between veterinary healthcare providers and technology companies has led to the
integration of artificial intelligence and machine learning in diagnostic
tools, further improving the accuracy and efficiency of cancer detection. This
shift toward advanced, data-driven diagnostics is enhancing the capabilities of
veterinary professionals and contributing to the market’s growth”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“United States Veterinary
Oncology Diagnostics Market By Animal Type (Canine, Feline, Others), By Test
Type (Blood Tests, Biopsy, Genome Testing, Endoscopy, Urinalysis, Imaging), By
Cancer Type (Lymphoma, Sarcomas, Mammary Gland Tumors, Skin Cancers, Others),
By End User (Reference Laboratories, Veterinary Hospitals and Clinics, Others),
By Region, Competition, Forecast & Opportunities, 2020-2030F”,
has evaluated the future growth potential of United States Veterinary Oncology
Diagnostics Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in United States Veterinary
Oncology Diagnostics Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com